Deutsche Bank’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Deutsche Bank’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-275,935	Closed	-$2.23M	–	4443
2021 Q3	$2.23M	Hold	275,935	–	–	﹤0.01%	2017
2021 Q2	$2.71M	Buy	275,935 +269,758	+4,367%	+$2.19M	﹤0.01%	1956
2021 Q1	$54K	Sell	6,177 -537	-8%	-$5.9K	﹤0.01%	4220
2020 Q4	$69K	Buy	6,714 +2,269	+51%	+$24.8K	﹤0.01%	4023
2020 Q3	$40K	Buy	4,445 +420	+10%	+$3.33K	﹤0.01%	3978
2020 Q2	$29K	Buy	4,025 +3,498	+664%	+$37.1K	﹤0.01%	3997
2020 Q1	$5K	Sell	527 -36	-6%	-$464	﹤0.01%	4153
2019 Q4	$7K	Buy	+563	New	+$6.87K	﹤0.01%	4602

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's GRTX Position: Q4 2021 in Review

Deutsche Bank sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 275,935 shares — an estimated $2.23M sold.

Deutsche Bank first reported a position in GRTX in Q4 2019 and held it in 8 quarters. The position peaked at $2.71M in Q2 2021. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

Deutsche Bank reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Deutsche Bank sold 275,935 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $2.23M.
Deutsche Bank first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
Deutsche Bank's Galera Therapeutics, Inc. Common Stock position peaked at $2.71M in Q2 2021.
44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.